Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.24839 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.13611 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.12653 | 48 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.03937 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.0468 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.31594 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.24092 | 49 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.12629 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.2229 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.09397 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.14301 | 48 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.06697 | 47 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.58536 | 60 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.14877 | 49 |